DeCode is located in Iceland and we all know what has happened to the economy in that country. Also they have been warned that their s tock may be taken off the Nasdaq index by October 30, if gains are not seen so they are feeling the recent downslides of the world economy slump. With all the progress...
Posted to
The Medical Quack .... by Barbara Duck
on 10-18-2008
Filed under: Medically Related, Technology, personalized medicine, Genomics, Breast Cancer, DeCode, DNA Testing, genetic testing, 23andMe
One of the first kits on the market, as the article states the test can assess whether breast cancer patients would benefit from Genentech's Herceptin cancer drug. The website as of today asks that you contact a sales person for additional information. BD The test, which received...
This is a big even in the move towards personalized medicine. This test will allow the physician to determine if the use of Herceptin is the right treatment for the patient with breast cancer! If it is determined not to work, then the patient is spared the expense and use of the drug, and...